Title |
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
|
---|---|
Published in |
Frontiers in immunology, July 2018
|
DOI | 10.3389/fimmu.2018.01519 |
Pubmed ID | |
Authors |
Lisa A. King, Roeland Lameris, Tanja D. de Gruijl, Hans J. van der Vliet |
Abstract |
CD1d-restricted invariant natural killer T (iNKT) cells are considered an attractive target for cancer immunotherapy. Upon their activation by glycolipid antigen and/or cytokines, iNKT cells can induce direct lysis of tumor cells but can also induce an antitumor immune response via their rapid production of proinflammatory cytokines that trigger the cytotoxic machinery of other components of the innate and adaptive immune system. Here, we provide an overview of various therapeutic approaches that have been evaluated or that are currently being developed and/or explored. These include administration of α-GalCer or alternative (glyco) lipid antigens, glycolipid-loaded antigen-presenting cells and liposomes, strategies that enhance CD1d expression levels or are based on ligation of CD1d, adoptive transfer of iNKT cells or chimeric antigen receptor iNKT cells, and tumor targeting of iNKT cells. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 11% |
Singapore | 1 | 11% |
Malaysia | 1 | 11% |
Spain | 1 | 11% |
Switzerland | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Scientists | 2 | 22% |
Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 71 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 20% |
Researcher | 11 | 15% |
Student > Bachelor | 9 | 13% |
Other | 4 | 6% |
Student > Master | 4 | 6% |
Other | 9 | 13% |
Unknown | 20 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 12 | 17% |
Biochemistry, Genetics and Molecular Biology | 10 | 14% |
Chemistry | 7 | 10% |
Agricultural and Biological Sciences | 6 | 8% |
Medicine and Dentistry | 5 | 7% |
Other | 9 | 13% |
Unknown | 22 | 31% |